Inflammatory Activity With IBD Tied to Impaired Sleep
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 9, 2025 -- Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms, according to a study published online June 26 in Clinical Gastroenterology and Hepatology.
Robert P. Hirten, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues used wearable devices to objectively assess the impact of inflammation and symptoms on sleep architecture in an observational study of adult patients with IBD. Inflammation was assessed via measurement of C-reactive protein, erythrocyte sedimentation rate, and fecal calprotectin, and symptoms were assessed via patient-reported outcome surveys. The analysis included 101 participants aged 18 years and older with a mean duration of 228.16 nights of wearable data.
The researchers found that periods with active inflammation were associated with a significantly smaller percentage of sleep time in rapid eye movement and a greater percentage of sleep time in light sleep. Altered sleep architecture was only seen when inflammation was present, but not symptoms. The rate of change in the percentage of time spent in deep and light sleep differed significantly before and after inflammatory and symptomatic flares.
"Our findings are crucial because they suggest that poor sleep may be related to active inflammatory disease, even when patients are not reporting symptoms," Hirten said in a statement. "This approach opens new possibilities for how wearable devices can monitor health events and track sleep in chronic diseases."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
THURSDAY, July 24, 2025 -- Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately to severely active Crohn...
Digital Model Based on Noninvasive Factors Shows Accuracy for Identifying IBD in Children
TUESDAY, July 22, 2025 -- A model based on noninvasive tests shows high accuracy as a digital tool for the rapid identification of children with inflammatory bowel disease (IBD)...
Healthy Plant-Based Diet May Lower Inflammatory Bowel Disease Risk
WEDNESDAY, July 16, 2025 -- A healthy plant-based diet may reduce the risk for inflammatory bowel disease (IBD) due to the anti-inflammatory properties of the diet, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.